Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform

Barry J. Oliver

Barry J. Oliver, vice president, Quality, Catalent Cell, Gene & Protein Therapies.

Articles by Barry J. Oliver

Latest Updated Articles